Carregant...
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
Recent advances in the field of cellular therapy have focused on autologous T cells engineered to express a chimeric antigen receptor (CAR) against tumor antigens. Remarkable responses have been observed in patients receiving autologous CD19- redirected T cells for the treatment B-lymphoid malignanc...
Guardat en:
| Publicat a: | Curr Opin Immunol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6140331/ https://ncbi.nlm.nih.gov/pubmed/29605760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2018.03.013 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|